Transplantation, AutologousBlood Transfusion, AutologousTreatment OutcomeHematopoietic Stem Cell TransplantationBone Marrow TransplantationCombined Modality TherapyStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsMelphalanMultiple MyelomaTime FactorsCyclophosphamideBone Marrow PurgingLymphoma, Non-HodgkinCytotoxicity, ImmunologicRemission InductionT-LymphocytesPeripheral Blood Stem Cell TransplantationCarmustineLymphocyte ActivationTransplantation, HomologousLymphocyte Culture Test, MixedT-Lymphocytes, CytotoxicRecurrenceFollow-Up StudiesDouble-Blind MethodTransplantation ConditioningAntigens, NeoplasmEtoposideCancer VaccinesHodgkin DiseaseSalvage TherapyDisease-Free SurvivalImmunotherapyCells, CulturedAntibodies, MonoclonalImmunotherapy, AdoptiveRetrospective StudiesProspective StudiesSurvival AnalysisDendritic CellsDrug Administration ScheduleDose-Response Relationship, DrugHematopoietic Stem Cell MobilizationAntineoplastic AgentsThiotepaWhole-Body IrradiationMelanomaDisease Models, AnimalDrug Therapy, CombinationCell TransplantationCytarabineAntigens, CD34Feasibility StudiesSurvival RateBone TransplantationInterleukin-2NeoplasmsPlatelet-Rich PlasmaVincristinePilot ProjectsGranulocyte Colony-Stimulating FactorAutograftsCell SeparationFlow CytometryLeukocytes, MononuclearLymphocytesDoxorubicinGraft SurvivalCoculture TechniquesHematopoietic Stem CellsClone CellsClinical Trials as TopicCD4-Positive T-LymphocytesAdministration, OralAntineoplastic Agents, AlkylatingDrug CombinationsGenetic TherapyBusulfanLymphomaRecombinant ProteinsLeukapheresisCD8-Positive T-LymphocytesKiller Cells, NaturalCytotoxicity Tests, ImmunologicRandomized Controlled Trials as TopicBone MarrowLymphocytes, Tumor-InfiltratingOperative Blood SalvageInterferon-gammaAntigens, CDTissue EngineeringPrognosisImmunophenotypingTumor Cells, CulturedRabbitsSafetyLeukemia, Myeloid, AcuteMesenchymal Stem Cell TransplantationCell Line, Tumor